Navigation Links
GenSpera's CEO Shares Insight on Unique Properties and Targeting of Lead Drug G-202, Based on the Thapsigargin Toxin
Date:8/5/2014

r industry peers is that G-202 is an active drug that does exactly what it is designed to do and at doses that are very well-tolerated by the patients.

Q: Investorideas.com
Can you talk about the multiple cancers that G-202 can potentially treat and the kind of market opportunity each represents?

A: Dr. Craig Dionne, PhD, GenSpera CEO
We expect G-202 to be useful in a wide range of malignant tumor types, which covers a multi-billion dollar industry opportunity for GenSpera. There are approximately 240,000 new cases of prostate cancer diagnosed in the US each year. The market for prostate cancer drugs is expected to reach $6.7 billion by 2020. Hepatocellular carcinoma is the third largest cancer killer worldwide with an expected market size of $1.5 billion by 2019. Glioblastoma is a smaller market but sales of the approved drug Avastin in those patients is expected to reach $460 million by 2017. However we view glioblastoma as a proof of concept for treating brain tumors; if successful, we expect that G-202 could be used to treat lung and breast cancers that metastasize to the brain, which is a 10-fold larger market than glioblastoma alone.

Q: Investorideas.com
How would you describe the G-202 proof of concept to-date in terms that an average reader could understand, outside of the scientific community?

A: Dr. Craig Dionne, PhD, GenSpera CEO
G-202 is designed to be activated only within the blood vessels of tumors and to kill those blood vessels directly, thus starving the tumors to death. We used a very sophisticated imaging technique to demonstrate that G-202 treatment nearly obliterated tumor blood flow in a liver cancer patient after only two cycles of treatment. These results bode well for our prostate cancer and glioblastoma (brain cancer) clinical trials, which use exactly the same dosing regimen.

Q: Investorideas.com
Craig with your recent data on
'/>"/>

SOURCE Investorideas.com
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018
2. Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share
3. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
4. My Cleaning Products Compiles Pictures of Bed Bugs, Shares How to Use Them Effectively to Eliminate the Pests
5. Probiotic Action Representative Fernando Perez Shares Tips for Parents with Teens Suffering from Acne and Depression
6. Don't Make That Critical Mistake That Rules Out Candidates From Job Interviews - Career Coach Shares Secrets to Impressive Interviewers
7. ResearchMoz: DSL Chips Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018 - Market Research Report
8. Unique Bed Bug Extermination Solution Revealed To The Public and Its Complimentary Sample Offered, MyCleaningProducts.com Shares Details Where to Get It
9. BioMed Realty Trust Prices Public Offering Of 12,700,000 Shares Of Common Stock
10. A Rust Remover That Saves Contractors $1,000 Now Offers Complimentary Samples, My Cleaning Products Shares Where to Get One
11. DistinctBright "The Best Probiotic Cleaner Company" Shares Tips for Green Cleaning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Steep Hill, the industry ... and internationally, intends to open a full service medical ... Mexico , bringing advanced scientific tools and methodology ... Steep Hill is currently the only laboratory licensed ... potency and contaminant testing in order to meet the ...
(Date:2/26/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... that develops and commercializes proprietary technologies and products for ... results for the fiscal first quarter ended December  31, ... Canadian dollars (CAD), unless otherwise stated. ... business from our existing customers and add to our ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The Movement ... demonstration to support life extension technologies and awareness. The ... Universal Coordinated Time, on March 21st 2015, in a ... , Eric Schulke, Founder of MILE, says, “Our ... with urgency. The Movement for Indefinite Life Extension is ...
(Date:2/26/2015)... February 26, 2015 The Pittcon ... at the Ernest N. Morial Convention Center in ... as of February 19, 2015) displaying products and ... academic, and government labs. The Exposition will offer ... not limited to, analytical chemistry; drug discovery; nanotechnology; ...
Breaking Biology Technology:Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3Pittcon 2015 Announces Exposition Highlights 2
... in Gastroenterology Panel Discussion, ISELIN, N.J., Dec. 10 ... Chief Executive Officer Elkan R. Gamzu,Ph.D. will participate in ... Healthcare Conference taking place December 12,- 13, 2007 at ... York, New York.,The panel is entitled "Going With Your ...
... Dan Gold, Ph.D., Joins as Chief Executive Officer, ... Applied,Biology, Inc. (FAB), a privately held biotechnology company, ... financing. Prior investor SV Life,Sciences (SVLS) led the ... from the financing will be used to develop ...
... EXTON, Pa., Dec 7 Kensey Nash Corporation,(Nasdaq: ... discussion on,"Helping the Body Regenerate Bone & Tissue" at ... Evans, Kensey Nash,s COO, will participate in the panel,discussion ... The Westin New,York at Times Square in New York. ...
Cached Biology Technology:Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference 2Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing 2Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing 3
(Date:2/19/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ) ... Electro-Optical / Infrared Systems Market by Type, by ... to 2020" report to their offering. ... expected to reach $16.35 billion by 2020, to ... report segments the military electro-optical/infrared systems market on ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)...   Epic Sciences , a precision diagnostics company dedicated ... Murali Prahalad , Ph.D., president and CEO, is scheduled to ... 2015: Silicon Valley, which is taking place at the Computer ... on January 26-28, 2015. Dr. Prahalad will ... Last year, Epic Sciences was a finalist in the PMWC,s ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... studies appearing in a recent issue of Cell ... http://www.ingentaconnect.com/content/cog/ct/ , evaluate stem cells derived from dental tissues ... appropriate for transplantation purposes. Induced pluripotent stem ... A Brazilian and American team of researchers used ...
... who invented a disease-fighting, anti-aging compound using nano-particles from ... Sanofi BioGENEius Challenge Canada (SBCC)., Her super anti-oxidant compound ... by neutralizing more of the harmful free-radicals found in ... a Grade 12 student at Waterloo Collegiate Institute, was ...
... of California, Riverside has identified a fungus that has been ... backyard avocado and landscape trees in residential neighborhoods of Los ... Fusarium . Scientists are working on ... Tea Shot Hole Borer ( Euwallacea fornicatus ), ...
Cached Biology News:2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes 22 Cell Transplantation studies impact dental stem cell research for therapeutic purposes 3Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles 2Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles 3Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles 4Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles 5Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles 6Beetle-fungus disease threatens crops and landscape trees in Southern California 2
Human Glypican 2 Biotinylated Affinity Purified PAb...
B2-Microgloulin...
... 120 utilizies CTI Molecular Imaging's proprietary Focus™ ... imaging volume as the R4. The ... of any commerically avaiable PET scanner. ... resolution of any scinitallor based PETsystems. ...
...
Biology Products: